In this study, a novel AgNbO3/Bi2MoO6/PANI double Z-scheme heterojunction photocatalyst was created via a solvothermal method, and the method investigates its photocatalytic degradation performance toward norfloxacin (NOR) and other antibiotics. When the content of AgNbO3 is 5 wt % and the content of PANI is 1 wt %, the rate of degradation of AgNbO3/Bi2MoO6/PANI on NOR under visible light is 95.56%, the rate of removal of total organic carbon is ∼57.45%, and its pseudo-first-order reaction rate constant is 0.01878 min–1, which surpasses those of AgNbO3, Bi2MoO6, and AgNbO3/Bi2MoO6 by factors of 14.22, 2.46, and 1.35, respectively. At the same time, the AgNbO3/Bi2MoO6/PANI photocatalyst still showed good stability after three cycles. The results demonstrated that the augmented photocatalytic performance of AgNbO3/Bi2MoO6/PANI can be attributed to the formation of a double Z-scheme heterojunction and the incorporation of PANI with excellent conductivity, resulting in the higher efficiency of migration of charge carriers while retaining strong redox ability. This work affords a high-efficiency and environmentally friendly reference for the development of a Bi2MoO6-based heterojunction photocatalyst and its application in the purification of antibiotics in water.
No takes yet. Share an insight, caveat, or question.
Xin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: